Christian Angermayer - 02 Jun 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Director, 10%+ Owner
Signature: /s/ Ryan Barrett, Attorney-in-fact
Issuer symbol: ATAI
Transactions as of: 02 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 04 Jun 2025, 16:38:51 UTC
Previous filing: 04 Oct 2024
Next filing: 27 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Angermayer Christian	Director, 10%+ Owner	66 & 67, BEATRICE, AMERY STREET, SLIEMA, MALTA	/s/ Ryan Barrett, Attorney-in-fact	04 Jun 2025	0001845872

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATAI	Stock Option	Award		+132K			132K	02 Jun 2025	Common Shares	132K	$2.49	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 2, 2025, the Issuer granted stock options to the Reporting Person in further consideration of his continued service as a consultant and other valuable consideration.
F2	The stock options shall vest as to 25% on June 2, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person entering into an amended consultancy agreement, the Reporting Person's continued service to the Issuer through each applicable vesting date and Apeiron Investment Group Ltd.'s compliance with the Voting Agreement dated as of June 2, 2025 by and among Beckley Psytech Limited, Atai Life Sciences N.V. and Apeiron Investment Group Ltd.

Content

On June 2, 2025, the Issuer granted stock options to the Reporting Person in further consideration of his continued service as a consultant and other valuable consideration.

The stock options shall vest as to 25% on June 2, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person entering into an amended consultancy agreement, the Reporting Person's continued service to the Issuer through each applicable vesting date and Apeiron Investment Group Ltd.'s compliance with the Voting Agreement dated as of June 2, 2025 by and among Beckley Psytech Limited, Atai Life Sciences N.V. and Apeiron Investment Group Ltd.